Clinical trialNCT00621504CompletedPhase 3Interventional

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

SponsorForest LaboratoriesEnrollment606Bacterial Pneumonia

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Thomas M File, MD, MS
Summa Health System
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

168 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Investigational Site
Buenos Aires, C.a.b.a., Argentina
Investigational Site
San Miguel de Tucumán, Tucumán Province, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Vicente López, Argentina

Austria

Investigational Site
Vienna, Austria
Investigational Site
Vienna, Austria

Brazil

Investigational Site
Goiânia, G.o., Brazil
Investigational Site
Porto Alegre, Rio Grande do Sul, Brazil
Investigational Site
Porto Alegre, Rio Grande do Sul, Brazil
Investigational Site
São José do Rio Preto, São Paulo, Brazil
Investigational Site 2
Belo Horizonte, Brazil
Investigational Site 1
Belo Horizonte MG, Brazil
Investigational Site
Campinas, Brazil
Investigational Site
Curitiba-PR, Brazil
Investigational Site
Juiz de Fora, Brazil
Investigational Site
Porto Alegre, Brazil
Investigational Site
São Paulo, Brazil
Investigational Site
São Paulo, Brazil

Bulgaria

Investigational Site
Burgas, Bulgaria
Investigational Site
Sofia, Bulgaria
Investigational Site
Varna, Bulgaria

Estonia

Investigational Site
Tallinn, Estonia
Investigational Site
Tallinn, Estonia
Investigational Site
Tartu, Estonia

France

Investigational Site
Annecy, France
Investigational Site
Argenteuil, France
Investigational Site
Paris, France
Investigational Site
Paris, France
Investigational Site
Paris, France

Georgia

Investigational Site
Tbilisi, Georgia
Investigational Site
Tbilisi, Georgia

Germany

Investigational Site
Lindenberger, State of Berlin, Germany
Investigational Site
Berlin, Germany
Investigational Site
Bochum, Germany

128 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2008
Primary completion: 31 Dec 2008
Completion: 30 Jun 2009
Last update posted: 14 Mar 2017
Registered enrollment: 606
Registry id: NCT00621504

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.